Head-to-Head

Kymera Therapeutics, Inc. Common Stock vs. X4 Pharmaceuticals, Inc. Common Stock

KYMR

Kymera Therapeutics, Inc. Common Stock

$124.87 -2.12%

VS XFOR

X4 Pharmaceuticals, Inc. Common Stock

$2.83 -9.29%

Kymera Therapeutics, Inc. Common Stock and X4 Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

KYMRXFOR
Market Cap $10.89 billion $318.59 million

KYMR leads on 1 of 1 size & scale factors.

Risk & Sentiment

KYMRXFOR
Short Interest 0.23% 0.08%

XFOR leads on 1 of 1 risk & sentiment factors.

Dig deeper: KYMR overview, KYMR financials, XFOR overview, XFOR financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.